A Multi-Task Deep-Learning System to Classify Diabetic Macular Edema for Different Optical Coherence Tomography Devices: A Multi-Centre Analysis
Fangyao Tang,Xi Wang,A. Ran,Carmen K M Chan,Maisie Ho,Wilson W K Yip,A. Young,Jerry K. H. Lok,Simon K H Szeto,Jason C. K. Chan,Fanny Yip,Raymond Wong,Ziqi Tang,Dawei Yang,Danny Ng,L. J. Chen,M. Brelen,Victor Chu,Ke-ning Li,Tracy H. T. Lai,G. Tan,D. Ting,Haifan Huang,H. Chen,J. Ma,Shibo Tang,T. Leng,Schahrouz Kakavand,Suria S. Mannil,Robert T. Chang,G. Liew,B. Gopinath,T. Lai,C. Pang,P. Scanlon,T. Wong,C. Tham,Hao Chen,P. Heng,C. Cheung
DOI: https://doi.org/10.2139/ssrn.3745217
2020-12-31
Abstract:Background: Diabetic macular edema (DME) is the primary cause of irreversible vision loss among individuals with diabetes mellitus (DM). We developed, validated, and tested a deep-learning (DL) system for classifying DME using images from three common commercially available optical coherence tomography (OCT) devices.
Methods: We trained and validated two versions of a multi-task network to classify DME (centre-involved DME [CI-DME], non-CI-DME, or absence of DME) using three-dimensional (3D) volume-scans and two-dimensional (2D) B-scans respectively. A total of 73,746 OCT images were used for training and primary validation. External testing was performed using 26,981 images across seven independent datasets from Singapore, Hong Kong, the US, China, and Australia.
Findings: In classifying the presence or absence of DME, the DL system achieved area under the receiver operating characteristic curves (AUROCs) of 0.937 (95% CI 0.920–0.954), 0.958 (0.930–0.977), and 0.965 (0.948–0.977) for primary datasets obtained from Cirrus, Spectralis, and Triton OCTs respectively, in addition to AUROCs greater than 0.906 for the external datasets. For the further classification of the CI-DME and non-CI-DME subgroups, the AUROCs were 0.968 (0.940–0.995), 0.951 (0.898–0.982), and 0.975 (0.947–0.991) for the primary datasets and greater than 0.894 for the external datasets.
Interpretation: We demonstrated excellent performance with a DL system for the automated classification of DME, highlighting its potential as a promising second-line screening tool for patients with DM, which will create a more effective triaging mechanism to tertiary eye clinics.
Funding: Research Grants Council General Research Fund, Hong Kong; Research to Prevent Blindness; and National Institutes of Health Grant.
Conflict of Interest: We report no potential conflicts of interest relevant to this article.
Ethical Approval: The current study presented here was conducted in accordance with the 1964 Declaration of Helsinki and was approved by local research ethics committees. Because the study is a retrospective analysis of fully anonymized OCT images, the ethics committees waived the requirements for informed consent.
Medicine